Emerging trends and new developments in monoclonal antibodies: A scientometric analysis (1980–2016)
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging trends and new developments in monoclonal antibodies: A scientometric analysis (1980–2016)
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 13, Issue 6, Pages 1388-1397
Publisher
Informa UK Limited
Online
2017-02-22
DOI
10.1080/21645515.2017.1286433
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting HER2 for the Treatment of Breast Cancer
- (2015) Mothaffar F. Rimawi et al. Annual Review of Medicine
- Strategies to overcome trastuzumab resistance in HER2-overexpressing breast cancers: focus on new data from clinical trials
- (2014) Pernelle Lavaud et al. BMC Medicine
- Emerging trends and new developments in regenerative medicine: a scientometric update (2000 – 2014)
- (2014) Chaomei Chen et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- The therapeutic monoclonal antibody market
- (2014) Dawn M Ecker et al. mAbs
- Orphan drugs and rare diseases: a scientometric review (2000 – 2014)
- (2014) Chaomei Chen et al. Expert Opinion on Orphan Drugs
- Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy
- (2013) D. T. Teachey et al. BLOOD
- Location Matters: Site of Conjugation Modulates Stability and Pharmacokinetics of Antibody Drug Conjugates
- (2013) Pavel Strop et al. CHEMISTRY & BIOLOGY
- Monoclonal antibody therapeutics: history and future
- (2012) Nicholas APS Buss et al. CURRENT OPINION IN PHARMACOLOGY
- Emerging trends in regenerative medicine: a scientometric analysis inCiteSpace
- (2012) Chaomei Chen et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Pharma interest surges in antibody drug conjugates
- (2011) Sarah Webb NATURE BIOTECHNOLOGY
- Sym004: A Novel Synergistic Anti-Epidermal Growth Factor Receptor Antibody Mixture with Superior Anticancer Efficacy
- (2010) M. W. Pedersen et al. CANCER RESEARCH
- Catumaxomab
- (2010) Rolf Linke et al. mAbs
- Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas
- (2010) Anas Younes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Towards an explanatory and computational theory of scientific discovery
- (2009) Chaomei Chen et al. Journal of Informetrics
- Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate
- (2008) G. D. Lewis Phillips et al. CANCER RESEARCH
- The thematic and citation landscape of Data and Knowledge Engineering (1985–2007)
- (2008) Chaomei Chen et al. DATA & KNOWLEDGE ENGINEERING
- Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
- (2008) Jagath R Junutula et al. NATURE BIOTECHNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started